Komori
Olympus (7733) · RiskAdvanced

Risk of Delayed Response to Technological Advances and Customer Needs

First written in FY2017. 3 of 5 entries say "Advanced", first in FY2019. Latest entry: FY2024.

5entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017AdvancedFY2018 – FY20242017: 120172018: 120182019: 120192020: 120202021: 020212022: 020222023: 020232024: 12024
Same theme, other companies

The whole theme swung hardest in 2026: 34 of 95 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 194 companies compared. The sentences above are computed from all 194.Comparing 200 of the theme's 471 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024AdvancedAnnual report

    「The principal achievements for the period included the European launches of the FlexLifter and SutuArt gastrointestinal endotherapy devices, the US launch of the ESG-410 energy generator compatible with the THUNDERBEAT surgical device, and the development of the POWRERSEAL Straight Jaw laparoscopic vessel-sealing device for connection to the ESG-410.」

    Made concrete progress in responding to technological advances and customer needs by developing and bringing to market endotherapy devices, energy devices and single-use flexible ureteroscopes.
  2. FY2020AdvancedAnnual report

    「In addition to our research and development to date, we will continue conducting research and development, marketing and sales activities for products and services while acquiring necessary technologies through alliances and open innovation.」

    With respect to responding to technological advances and customer needs, explicitly states that necessary technologies will be acquired not only through research and development but also through alliances and open innovation.
  3. FY2019AdvancedAnnual report

    「The principal achievements for the period included the development of NoviSight software incorporating 3D cell analysis technology expected to improve research efficiency and reduce risks in the drug discovery market, and the IPLEX G Lite and IPLEX GX/GT industrial videoscopes for manufacturing and maintenance markets covering power generation equipment, aircraft engines and automobiles.」

    Advanced responses to technological advances and customer needs in the Scientific Solutions Business by developing 3D cell analysis software and industrial videoscopes.
  4. FY2018MitigatedAnnual report

    「The principal achievements for the period included the development of two upright models of the FV3000 confocal laser scanning microscope, which can observe ultrafast signal transmission in the nervous system and other phenomena at an industry-leading imaging speed of 438 frames per second, and the LEXT OLS5000 3D measuring laser microscope, which substantially improves measurement performance through features including 4K scanning technology and dedicated LEXT optics and achieves data acquisition at four times the speed of previous models.」

    Describes new product development achievements demonstrating responsiveness to technological advances and customer needs in the Scientific Solutions Business, including imaging at 438 frames per second and data acquisition at four times the previous speed.
  5. FY2017First statedAnnual report

    「We continue to develop products using cutting-edge technologies. However, because technology is advancing rapidly, if we cannot adequately anticipate market changes and develop new products that meet customer needs in a timely manner, this could affect our ability to secure earnings.」

    Identifies as a new risk the possibility that new product development may lag behind customer needs because technological advances and market changes cannot be anticipated.
Moved together

"Global Compliance Management System" moved the same way as this thread, in the same document, in 4 of its 5 moves.

444443★123456
  1. ★This thread
  2. 1Global Compliance Management System4×
  3. 2Establishment of a Company-Wide Quality Management System4×
  4. 3Further expansion of operations centered on the healthcare business4×
  5. 4Restructuring the Business Portfolio and Optimizing the Allocation of Management Resources4×
  6. 5Organization-Wide Strengthening of Information Security4×
  7. 6Reviewing the Rationale for Cross-Shareholdings and Exercising Voting Rights3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Olympus yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Delayed Response to Technological Advances and Customer Needs | OLYMPUS CORPORATION (7733) | Komori